Literature DB >> 16723627

Stimulant medications and attention deficit-hyperactivity disorder.

Adam L Cohen, Michael A Jhung, Daniel S Budnitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16723627     DOI： 10.1056/NEJMc060860

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Authors:  Laurel A Habel; William O Cooper; Colin M Sox; K Arnold Chan; Bruce H Fireman; Patrick G Arbogast; T Craig Cheetham; Virginia P Quinn; Sascha Dublin; Denise M Boudreau; Susan E Andrade; Pamala A Pawloski; Marsha A Raebel; David H Smith; Ninah Achacoso; Connie Uratsu; Alan S Go; Steve Sidney; Mai N Nguyen-Huynh; Wayne A Ray; Joe V Selby
Journal:  JAMA       Date:  2011-12-12       Impact factor: 56.272

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

4.  Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark Olfson; Cecilia Huang; Tobias Gerhard; Almut G Winterstein; Stephen Crystal; Paul D Allison; Steven C Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-20       Impact factor: 8.829

5.  Emergency Department Visits for Adverse Events Related to Dietary Supplements.

Authors:  Andrew I Geller; Nadine Shehab; Nina J Weidle; Maribeth C Lovegrove; Beverly J Wolpert; Babgaleh B Timbo; Robert P Mozersky; Daniel S Budnitz
Journal:  N Engl J Med       Date:  2015-10-15       Impact factor: 91.245

6.  Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry.

Authors:  R Hamilton; C Gray; S A Bélanger; A E Warren; R M Gow; S Sanatani; J-M Côté; J Lougheed; J LeBlanc; S Martin; B Miles; C Mitchell; D A Gorman; M Weiss; R Schachar
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-11

7.  The nonmedical use of prescription ADHD medications: results from a national Internet panel.

Authors:  Scott P Novak; Larry A Kroutil; Rick L Williams; David L Van Brunt
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.